Propranolol promotes Egr1 gene expression in cardiomyocytes via β-adrenoceptors

European Journal of Pharmacology

Volumn 587, Issue 1-3, 2008, Pages 85-89

  Patrizio, Mario ^a   Musumeci, Marco ^a   Stati, Tonino ^a   Fecchi, Katia ^a   Mattei, Elisabetta ^c   Catalano, Liviana ^b   Marano, Giuseppe ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b Centro Nazionale Trasfusione Sangue   (Italy)

^c CNR   (Italy)

Author keywords

Adrenoceptors; Cardiomyocytes; Egr1; Gene expression; Propranolol

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; EARLY GROWTH RESPONSE FACTOR 1; ISOPRENALINE; MESSENGER RNA; PROPRANOLOL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; C57BL 6 MOUSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVATION; GENE EXPRESSION; HEART LEFT VENTRICLE; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NEWBORN; NONHUMAN; OSMOTIC MINIPUMP; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; REAL TIME POLYMERASE CHAIN REACTION;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; BLOOD PRESSURE; BLOTTING, WESTERN; CATECHOLAMINES; CELLS, CULTURED; EARLY GROWTH RESPONSE PROTEIN 1; ELECTROCARDIOGRAPHY; GENE EXPRESSION; MALE; MICE; MICE, INBRED C57BL; MYOCYTES, CARDIAC; PROPRANOLOL; RECEPTORS, ADRENERGIC, BETA; RNA, MESSENGER; UP-REGULATION; VENTRICULAR FUNCTION, LEFT;

EID: 44149103097     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.04.017     Document Type: Article

References (15)

1. Azzi M., Piñeyro G., Pontier S., Parent S., Ansanay H., and Bouvier M. Allosteric effects of G protein overexpression on the binding of β-adrenergic ligands with distinct inverse efficacies. Mol. Pharmacol. 60 (2001) 999-1007
2. Azzi M., Charest P.G., Angers S., Rousseau G., Kohout T., Bouvier M., and Piñeyro G. β-adrenoceptorrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors. Proc. Natl. Acad. Sci. U S A. 100 (2003) 11406-11411
3. 2-adrenoceptor provide evidence for agonist-directed signaling. Mol. Pharmacol. 64 (2003) 1357-1369
4. Boluyt M., Long X., Eschenhagen T., Mende U., Schmitz W., Crow M.T., and Lakatta E.G. Isoproterenol infusion induces alterations in expression of hypertrophy-associated genes in rat heart. Am. J. Physiol. 269 (1995) H638-H647
5. Buitrago M., Lorenz K., Maass A.H., Oberdorf-Maass S., Keller U., Schmitteckert E.M., Ivashchenko Y., Lohse M.J., and Engelhardt S. The transcriptional repressor Nab1 is a specific regulator of pathological cardiac hypertrophy. Nat. Med. 11 (2005) 837-844
6. Galandrin S., and Bouvier M. Distinct signaling profiles of β1 and β2 adrenergic receptor ligands toward adenylyl cyclase and mitogen-activated protein kinase reveals the pluridimensionality of efficacy. Mol. Pharmacol. 70 (2006) 1575-1584
7. 1A cells J. Biol. Chem. 276 (2001) 39394-39403
8. Keys J.R., Greene E.A., Koch W.J., and Eckhart A.D. Gq-coupled receptor agonists mediate cardiac hypertrophy via the vasculature. Hypertension 40 (2002) 660-666
9. - ΔΔCT method. Methods 25 (2001) 402-408
10. + exchange inhibition attenuates left ventricular remodeling and preserves systolic function in pressure-overloaded hearts. Br. J. Pharmacol. 141 (2004) 526-532
11. Saadane N., Alpert L., and Chalifour L.E. Expression of immediate early genes, GATA-4, and Nkx-2.5 in adrenergic-induced cardiac hypertrophy and during regression in adult mice. Br. J. Pharmacol. 127 (1999) 1165-1176
12. Saadane N., Alpert L., and Chalifour L.E. Altered molecular response to adrenoreceptor-induced cardiac hypertrophy in Egr-1-deficient mice. Am. J. Physiol. 278 (2000) H796-H805
13. Sadoshima J., Jahn L., Takahashi T., Kulik T.J., and Izumo S. Molecular characterization of the stretch-induced adaptation of cultured cardiac cells. An in vitro model of load-induced cardiac hypertrophy. J. Biol. Chem. 267 (1992) 10551-10560
14. Wei H., Ahn S., Barnes W.G., and Lefkowitz R.J. Stable interaction between β-adrenoceptorrestin 2 and angiotensin type 1A receptor is required for β-adrenoceptorrestin 2-mediated activation of extracellular signal-regulated kinases 1 and 2. J. Biol. Chem. 279 (2004) 48255-48261
15. Zhang G.X., Ohmori K., Nagai Y., Fujisawa Y., Nishiyama A., Abe Y., and Kimura S. Role of AT1 receptor in isoproterenol-induced cardiac hypertrophy and oxidative stress in mice. J. Mol. Cell. Cardiol. 42 (2007) 804-811